Drug intelligence / Profile preview

KSL-W

Development stage
Phase 2
Modality
Peptides
Administration
Buccal, Topical, Oral
01

Overview

KSL-W is a synthetic antimicrobial decapeptide with the sequence H-Lys-Lys-Val-Val-Phe-Trp-Val-Lys-Phe-Lys-NH2. It has a molecular weight of 1307.67 Da and molecular formula C68H106N16O10. It is a synthesized analogue of KSL (KKVVFKVKFK), designed with an amidated C-terminus (NH2) and improved stability in simulated oral and gastric conditions while maintaining antimicrobial properties. It is typically available in powder form. KSL-W demonstrates broad-spectrum antimicrobial activity against: * Gram-positive bacteria * Gram-negative bacteria * Fungi (e.g., *Candida albicans*) * Viruses It also exhibits immunomodulatory effects, including enhancing neutrophil chemotaxis, increasing F-actin polymerization in neutrophils, and inhibiting oxygen radical production in stimulated neutrophils. It has advanced to human clinical trials for oral health applications, showing safety and proof-of-concept efficacy in reducing plaque and gingival inflammation.

02

Targets

NOX2 (NADPH oxidase 2)

Beyond the preview

Go deeper on KSL-W.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KSL-W.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call